PET-CT for Lung Cancer — What It Stages and How It Changes Treatment

No — a PET-CT cannot confirm a cancer diagnosis. The scan shows where there is high metabolic activity, which can come from cancer but also from infection, inflammation, TB, or healing tissue. It is used for staging, to show how far disease has spread, not to make the diagnosis itself. The diagnosis always requires a biopsy of the tumour tissue. A PET-CT finding in a lymph node or distant organ also needs tissue confirmation before it changes your treatment plan.

A CT scan shows anatomy — the size and location of a tumour or lymph node. A PET-CT adds metabolic information, showing which areas are consuming glucose at a higher rate than normal. This helps identify lymph node involvement and distant spread that CT alone can miss in a proportion of patients. For staging decisions — particularly whether surgery is possible — PET-CT gives your oncologist information that CT cannot provide on its own.

Yes, and the scan remains useful. TB and lung cancer can occur in the same patient, and your oncologist and radiologist will take your TB history into account when interpreting the report. Any lymph node finding that would change your stage from operable to inoperable will typically need biopsy confirmation before a treatment decision is made. Tell your care team your full TB history, including old or treated infections, so the report is read in the right context.

Plan for two to two-and-a-half hours in total. After the radioactive tracer is injected, you wait quietly for about an hour while it distributes through your body — that waiting time is necessary, not optional. The scan itself takes around 20 to 30 minutes. You will need to fast beforehand, usually for several hours, because blood sugar levels affect how the tracer distributes. Your imaging team will give you the specific preparation instructions when the appointment is made.

It is one of the most important inputs into that question. PET-CT shows the extent of disease — whether lymph nodes are involved, whether the cancer has spread beyond the chest — which is essential for deciding whether surgery is feasible. But the final decision also depends on your lung function, your overall fitness for an operation, and biopsy confirmation of any suspicious lymph nodes the scan identifies. The PET-CT starts that conversation; your surgical team completes it.

PET-CT is coordinated through partner imaging centres rather than performed at CION's own facilities. Your care team will refer you, arrange the scan, and review the report as part of your overall treatment planning. You do not need to book it independently or find a centre yourself. The report is reviewed alongside your clinical assessment before any treatment decision is made.